Pendal Group’s Bausch Health BHC Stock Holding History

Pendal Group’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$5.39M	Buy	858,684 +777,084	+952%	+$5.43M	0.05%	149
2022 Q3	$563K	Buy	+81,600	New	+$567K	0.01%	334
2021 Q4	–	Sell	-534,290	Closed	-$14.9M	–	551
2021 Q3	$14.9M	Buy	534,290 +483,107	+944%	+$13.7M	0.12%	103
2021 Q2	$1.5M	Buy	+51,183	New	+$1.55M	0.01%	287
2021 Q1	–	Sell	-12,628	Closed	-$262K	–	540
2020 Q4	$262K	Buy	+12,628	New	+$236K	﹤0.01%	465
2019 Q3	–	Sell	-9,326	Closed	-$308K	–	452
2019 Q2	$308K	Buy	+9,326	New	+$221K	﹤0.01%	380
2018 Q3	–	Sell	-10,328	Closed	-$316K	–	449
2018 Q2	$316K	Buy	+10,328	New	+$214K	﹤0.01%	403

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Pendal Group's BHC Position: Q4 2022 in Review

Pendal Group increased its Bausch Health (BHC) stake by 952% in Q4 2022, buying an estimated $5.43M and bringing the position to 858,684 shares worth $5.39M. The position accounts for 0.05% of the portfolio, ranked #149.

Pendal Group first reported a position in BHC in Q2 2018 and has held it in 7 quarters since. The position peaked at $14.9M in Q3 2021. 262 funds tracked by Wall St. Rank hold BHC as of Q4 2022.

Pendal Group held 858,684 shares of Bausch Health worth $5.39M as of Q4 2022.
Pendal Group bought 777,084 Bausch Health shares in Q4 2022, an estimated $5.43M.
Bausch Health made up 0.05% of Pendal Group's portfolio in Q4 2022, its #149 holding.
Pendal Group first reported a position in Bausch Health in Q2 2018 and has held it in 7 quarters since.
Pendal Group's Bausch Health position peaked at $14.9M in Q3 2021.
262 funds tracked by Wall St. Rank held Bausch Health as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.